Search for: "Matter of Lilly"
Results 261 - 280
of 740
Sorted by Relevance
|
Sort by Date
6 Nov 2015, 4:39 am
For Hoffman, at the end of the day, the intangible asset that really matters is the network. [read post]
14 Mar 2016, 3:23 am
Via Katfriend Federica Pezza (LLM candidate, Queen Mary University of London) comes the news that yet another culinary IP battle is now taking place in a country where food indeed matters: Italy.* Where has the patent troll gone? [read post]
25 Apr 2017, 6:00 am
"The Lilly mega judgment on "educated guess"The notion that there needs to be support e.g. in the form of (rudimentary?) [read post]
11 Nov 2024, 2:32 am
Indeed, Isomorphic has already announced drug-discovery collaborations with big pharma companies Eli Lilly and Novartis. [read post]
17 Mar 2022, 2:32 pm
Eli Lilly & Co., 119 F.3d 1559, 1568 (Fed. [read post]
13 May 2014, 9:23 am
"All this is compliant with the GAT and Folien decisions and the Corte di Cassazione ruling, as well the UK decision in Joined cases Actavis Group hf v Eli Lilly & Company (USA) and Medis ehf v Eli Lilly & Company (USA) [here]. [read post]
1 Apr 2008, 10:57 am
Instead, they centered on work-related matters. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging… [read post]
10 Jul 2017, 1:00 am
This appeal considered whether a new pemetrexed based cancer treatment produced by Actavis UK Ltd and others infringes Eli Lilly & Co’s patent and its foreign designations either indirectly under the Patents Act 1977, s 60(2) (matter for appeal) or directly under a proper interpretation of the Europe Patent Convention 2000, art 69 (matter for cross-appeal). [read post]
29 May 2012, 8:17 am
Eli Lilly & Co. and Jirak v. [read post]
15 Jul 2010, 2:39 pm
Eli Lilly & Co., 192 Cal. [read post]
13 Oct 2015, 11:42 am
Thierry Calame (Lenz & Staehelin), the Committee's Co-Chair, lead the panel session with an expert panel including Judge Meier-Beck (Presiding Judge of the German Federal Court of Justice), Larry Welch (Eli Lilly), Tina Chappell (Intel) and Michael Frohlich. [read post]
17 Oct 2017, 6:09 pm
Innovator v Innovator - does this matter where injunctions are concerned? [read post]
10 Aug 2014, 7:52 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
21 May 2010, 8:58 am
Eli Lilly &Co. fell short of that requirement. [read post]
5 Feb 2009, 6:44 am
Congress did fix the Court’s wrong, and on January 29 of this year President Obama signed into law the Lilly Ledbetter Fair Pay Act. [read post]
6 Jul 2010, 3:23 pm
Then there is the matter of illegal immigration. [read post]
10 Feb 2011, 5:35 pm
The district court ruled in Sun’s favor, and Lilly appealed to the U.S. [read post]
21 Jun 2016, 4:00 am
The court only noted in passing that Lilly and its main expert sought to rely on apparent “in-house test data” that does not appear to have been in the public realm at the time of filing (para. 51). [read post]
26 Jan 2012, 8:23 am
The Dodd-Frank Act endorsed this approach and further prohibited discretionary broker votes on executive compensation matters, including management say-on-pay votes. [read post]
